In the present study, we investigated the time limit of IFNβ treatment on the extension of tPA therapeutic window and assessed the effect of IFNβ on the modulation of MG phenotypes in delayed tPA-treated stroke animals. The gene discussed is IFNB1; the disease is stroke disorder.